Tagworks Pharmaceuticals BV (TAG)
Scientist in Charge: Marc Robillard
Tagworks Pharmaceuticals BV, a Philips Research spin out, is developing a unique approach towards antibody-based imaging and therapy. Tagworks’ 
technology enables the actuation of tagged antibodies through selective bio-orthogonal chemical manipulation in vivo, improving the efficacy of established approaches such as Radioimmuno-imaging and –therapy and Antibody-Drug Conjugates.